Hope Bancorp (HOPE) Moves to Buy: Rationale Behind the Upgrade
Hope Bancorp (HOPE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Hope Bancorp (HOPE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Hope Bancorp (HOPE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hope Bancorp (HOPE) Q2 Earnings and Revenues Surpass Estimates
Hope Bancorp (HOPE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.19 per share a year ago.
Hope Bancorp, Inc. (HOPE) Shareholder/Analyst Call Prepared Remarks Transcript
Hope Bancorp, Inc. (HOPE) Shareholder/Analyst Call Prepared Remarks Transcript
Hope Bancorp, Inc. (HOPE) Q1 2026 Earnings Call Transcript
Hope Bancorp, Inc. (HOPE) Q1 2026 Earnings Call Transcript
Hope Bancorp (HOPE) Q1 Earnings Surpass Estimates
Hope Bancorp (HOPE) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.
Here's Why Hope Bancorp (HOPE) is a Great Momentum Stock to Buy
Does Hope Bancorp (HOPE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel
Capricor Therapeutics is upgraded from 'Hold' to 'Buy' following FDA acceptance of the HOPE-3 clinical study report for Deramiocel in DMD cardiomyopathy. The FDA lifted the Complete Response Letter and set a PDUFA date of August 22, 2026, without requiring new studies, increasing regulatory clarity. Phase 3 HOPE-3 data showed Deramiocel slowed disease progression by 54% [PUL] and 91% [LVEF], with additional functional and fibrosis benefits.
Hope Bancorp, Inc. (HOPE) Q4 2025 Earnings Call Transcript
Hope Bancorp, Inc. (HOPE) Q4 2025 Earnings Call Transcript
Hope Bancorp (HOPE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Hope Bancorp (HOPE) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Hope Bancorp (HOPE) Q4 Earnings and Revenues Beat Estimates
Hope Bancorp (HOPE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.2 per share a year ago.
Hope Bancorp (HOPE) Surges 5.5%: Is This an Indication of Further Gains?
Hope Bancorp (HOPE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
